| scholarly article | Q13442814 |
| P50 | author | Matthias Dobbelstein | Q38322479 |
| P2093 | author name string | Judith Roth | |
| Manuela C Koch | |||
| Alexandra Dittmer | |||
| Ana Contente | |||
| P2860 | cites work | Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein | Q24309481 |
| A model for p53-induced apoptosis | Q24313374 | ||
| The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression | Q24533291 | ||
| A simplified system for generating recombinant adenoviruses | Q24682328 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein | Q28238628 | ||
| Kinetics of p53 binding to promoter sites in vivo | Q33558659 | ||
| Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest | Q33774492 | ||
| Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. | Q33888123 | ||
| Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53 - MDM2 complexes | Q34055205 | ||
| p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs | Q36401199 | ||
| E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. | Q38317803 | ||
| Regulation of the specific DNA binding function of p53 | Q38324290 | ||
| A transcriptionally active DNA-binding site for human p53 protein complexes | Q40655196 | ||
| Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations | Q41037063 | ||
| The polyproline region of p53 is required to activate apoptosis but not growth arrest. | Q41093439 | ||
| p53 induces TAP1 and enhances the transport of MHC class I peptides | Q73318914 | ||
| Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain | Q73703327 | ||
| Evolution of simple repeats in DNA and their relation to human disease | Q77058046 | ||
| Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity | Q77733994 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microsatellite | Q265193 |
| P304 | page(s) | 315-320 | |
| P577 | publication date | 2002-02-04 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | A polymorphic microsatellite that mediates induction of PIG3 by p53. | |
| P478 | volume | 30 |
| Q92597250 | A Long Polymorphic GT Microsatellite within a Gene Promoter Mediates Non-Imprinted Allele-Specific DNA Methylation of a CpG Island in a Goldfish Inter-Strain Hybrid |
| Q36850622 | A brief review of short tandem repeat mutation |
| Q34574817 | A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. |
| Q24298536 | A novel response element confers p63- and p73-specific activation of the WNT4 promoter |
| Q57798860 | A reference haplotype panel for genome-wide imputation of short tandem repeats |
| Q35777548 | A survey of tandem repeat instabilities and associated gene expression changes in 35 colorectal cancers |
| Q36678322 | A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis |
| Q34504259 | Abundant contribution of short tandem repeats to gene expression variation in humans |
| Q38353498 | Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding. |
| Q78675653 | Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region |
| Q35781362 | BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner |
| Q35913092 | CYP2C9 promoter variable number tandem repeat polymorphism regulates mRNA expression in human livers. |
| Q38911126 | Census and evaluation of p53 target genes. |
| Q36777343 | Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson |
| Q38291053 | Characterization of genome-wide p53-binding sites upon stress response. |
| Q34961997 | Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions. |
| Q37582400 | Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway |
| Q30816662 | Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathway |
| Q35116663 | Decision making by p53: life, death and cancer |
| Q38348098 | DeltaNp73 can modulate the expression of various genes in a p53-independent fashion |
| Q36241935 | Development and progression of colorectal neoplasia |
| Q38324246 | Differential recognition of response elements determines target gene specificity for p53 and p63 |
| Q73876731 | Differential regulation of p63 and p73 expression |
| Q48289265 | Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. |
| Q108126987 | Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network |
| Q28757271 | Divergent evolution of human p53 binding sites: cell cycle versus apoptosis |
| Q37122075 | Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells |
| Q35834497 | Dynamics of Transcription Factor Binding Site Evolution. |
| Q40541104 | E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection |
| Q52341021 | Effects on gene expression and behavior of untagged short tandem repeats: the case of arginine vasopressin receptor 1a (AVPR1a) and externalizing behaviors. |
| Q34621360 | Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes |
| Q35229441 | Environmental stress induces trinucleotide repeat mutagenesis in human cells |
| Q40290190 | Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription. |
| Q58712829 | Forensic characterization and genetic polymorphisms of 19 X-chromosomal STRs in 1344 Han Chinese individuals and comprehensive population relationship analyses among 20 Chinese groups |
| Q42096577 | Functional Mechanisms of Microsatellite DNA in Eukaryotic Genomes. |
| Q30479523 | Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity |
| Q36740684 | Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck |
| Q34325529 | Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes |
| Q40163624 | Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73. |
| Q39819083 | Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. |
| Q36948999 | Gene regulation as a modulator of social preference in voles |
| Q44940173 | Genetic control of autoantibody expression in autoimmune myasthenia gravis: role of the self-antigen and of HLA-linked loci. |
| Q34555765 | Genome-wide profiling of heritable and de novo STR variations. |
| Q38867373 | Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A. |
| Q78484469 | Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites |
| Q36054564 | HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions |
| Q33316864 | High frequency of microsatellites in S. cerevisiae meiotic recombination hotspots |
| Q40484325 | Identification of a putative p53 binding sequence within the human mitochondrial genome |
| Q40263007 | Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression |
| Q92582109 | Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling |
| Q40991008 | Identification of p53-target genes in Danio rerio |
| Q34138144 | Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif |
| Q64067200 | Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease |
| Q35652294 | In vitro analysis of DNA-protein interactions by proximity ligation |
| Q28240630 | Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA |
| Q37014644 | Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites |
| Q40540682 | Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. |
| Q24293273 | Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif |
| Q35131580 | Insights into the mitochondrial signaling pathway: what lessons for chemotherapy? |
| Q29547663 | Live or let die: the cell's response to p53 |
| Q47761816 | Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias. |
| Q34039841 | Mechanisms of regulatory diversity within the p53 transcriptional network |
| Q40949623 | Methyl methanesulfonate induces necroptosis in human lung adenoma A549 cells through the PIG-3-reactive oxygen species pathway |
| Q36786777 | Microsatellites as EWS/FLI response elements in Ewing's sarcoma |
| Q41887497 | Microsatellites with macro-influence in ewing sarcoma |
| Q39776556 | Mutual interference of adenovirus infection and myc expression |
| Q36821389 | Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoires |
| Q49850977 | On the design of CRISPR-based single-cell molecular screens |
| Q41837471 | Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters |
| Q33878303 | PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination |
| Q37680199 | PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients |
| Q36870569 | Polymorphic tandem repeats within gene promoters act as modifiers of gene expression and DNA methylation in humans |
| Q37293815 | Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment |
| Q36002527 | Population-Scale Sequencing Data Enable Precise Estimates of Y-STR Mutation Rates |
| Q28214642 | Post-genomic era and gene discovery for psychiatric diseases: there is a new art of the trade? The example of the HUMTH01 microsatellite in the Tyrosine Hydroxylase gene |
| Q33525265 | Recombination and its impact on the genome of the haplodiploid parasitoid wasp Nasonia |
| Q33482051 | Regression based predictor for p53 transactivation |
| Q42276830 | STRScan: targeted profiling of short tandem repeats in whole-genome sequencing data |
| Q33706693 | Search for informative polymorphisms in candidate genes: clock genes and circadian behaviour in blue tits |
| Q35832028 | Serum withdrawal up-regulates human SIRT1 gene expression in a p53-dependent manner. |
| Q42374467 | Single nucleotide polymorphisms and microsatellites in the canine glutathione S-transferase pi 1 (GSTP1) gene promoter |
| Q38363728 | Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain |
| Q36500275 | Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53. |
| Q45316772 | TP53 Regulates Transcription of Cell Death Genes |
| Q50290242 | TP53 family members bind the TP53I3 (PIG3) gene promoter |
| Q45316776 | TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain |
| Q50290243 | TP53 stimulates expression of the TP53I3 (PIG3) gene |
| Q49339127 | Tandem repeats mediating genetic plasticity in health and disease |
| Q50592601 | Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis. |
| Q24556628 | The C terminus of p53 family proteins is a cell fate determinant |
| Q35191541 | The complex interactions of p53 with target DNA: we learn as we go. |
| Q37602507 | The expanding universe of p53 targets |
| Q91063049 | The impact of short tandem repeat variation on gene expression |
| Q34439408 | The landscape of human STR variation |
| Q78840634 | The mouse Ink4a/Arf locus: a p53 pile-up at a tumour surveillance crossroads? |
| Q37689537 | The oncogenic effects of p53-inducible gene 3 (PIG3) in colon cancer cells |
| Q39761186 | The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage |
| Q57035038 | The p53-inducible gene 3 promotes cell migration and invasion via activating the FAK/Src pathway in lung adenocarcinoma |
| Q33432306 | The p53HMM algorithm: using profile hidden markov models to detect p53-responsive genes |
| Q36392179 | The transcription factor CREBZF is a novel positive regulator of p53. |
| Q24273295 | The transcription factor p53: not a repressor, solely an activator |
| Q24313288 | Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3 |
| Q38621771 | Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. |
| Q29617650 | Transcriptional control of human p53-regulated genes |
| Q37777267 | Transcriptional regulation by p53. |
| Q36436698 | Transcriptional regulation by p53: one protein, many possibilities |
| Q36703594 | Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation. |
| Q34311385 | UV-dependent alternative splicing uncouples p53 activity and PIG3 gene function through rapid proteolytic degradation |
| Q37087404 | Versatile functions of p53 protein in multicellular organisms |
| Q84526775 | Why is p53-inducible gene 3 rarely affected in cancer? |
| Q81554284 | Wild-type p53 stimulates homologous recombination upon sequence-specific binding to the ribosomal gene cluster repeat |
| Q24338336 | hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes |
| Q40647697 | p21/CDKN1A mediates negative regulation of transcription by p53. |
| Q34911119 | p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner |
| Q47140890 | p53 binding sites in normal and cancer cells are characterized by distinct chromatin context. |
| Q24298888 | p53 has a direct apoptogenic role at the mitochondria |
| Q39714641 | p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage |
| Q34710473 | p53 leans on its siblings |
| Q37376012 | p53 polymorphisms: cancer implications |
| Q35718450 | p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. |
| Q33565827 | p53-mediated heterochromatin reorganization regulates its cell fate decisions |
Search more.